End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.8 USD | 0.00% |
|
-0.42% | +5.08% |
Jun. 11 | BofA Securities Adjusts Oculis Holding AG to $20 From $21, Maintains Buy Rating | MT |
Jun. 11 | Baird Adjusts Price Target on Oculis Holding to $37 From $35, Maintains Outperform Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
493M | - | |||||
53.67B | - | |||||
38.86B | ||||||
38.76B | ||||||
27.27B | ||||||
25.91B |
- Stock Market
- Equities
- OCS Stock
- Charts Oculis Holding AG
- Sector Chart